CIK 0000744218 · Large accelerated filer
Celldex Therapeutics, Inc.
Sign in to watch- Ticker
- CLDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133191702
- Phone
- 908-200-7500
- Business address
- 53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
- Former names
- AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Director gave up 2,824 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 2,888 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 2,888 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 2,813 shares (to pay taxes)
- 4 Open-market buy Director bought 40,000 shares at $0.48 ($19,200)
- 4 Shares withheld for taxes Director gave up 2,813 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 2,813 shares (to pay taxes)
- 4 Open-market buy Executive VP & CSO bought 16,500 shares at $0.59 ($9,783)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 10 of 26 · 516 filings